Healthcare provider profile · identity verified

Christopher R Smith, MD

Internal Medicine · WELLESLEY, MA · NPI 1992758528

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	503	152
Amlodipine Besylate	Amlodipine Besylate	260	82
Lisinopril	Lisinopril	225	69
Levothyroxine Sodium	Levothyroxine Sodium	207	60
Lorazepam	Lorazepam	207	45
Rosuvastatin Calcium	Rosuvastatin Calcium	207	65
Omeprazole	Omeprazole	206	58
Metoprolol Succinate	Metoprolol Succinate	198	55
Losartan Potassium	Losartan Potassium	181	50
Hydrochlorothiazide	Hydrochlorothiazide	143	39
Eliquis	Apixaban	125	34
Metformin Hcl Er	Metformin Hcl	120	39
Tamsulosin Hcl	Tamsulosin Hcl	118	33
Alprazolam	Alprazolam	116	30
Gabapentin	Gabapentin	106	29
Sertraline Hcl	Sertraline Hcl	106	30
Simvastatin	Simvastatin	98	28
Allopurinol	Allopurinol	95	29
Zolpidem Tartrate	Zolpidem Tartrate	91	36
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	90	23
Oxycodone Hcl	Oxycodone Hcl	81	12
Pravastatin Sodium	Pravastatin Sodium	68	17
Clonazepam	Clonazepam	66	13
Trazodone Hcl	Trazodone Hcl	66	25
Albuterol Sulfate Hfa	Albuterol Sulfate	65	25
Pantoprazole Sodium	Pantoprazole Sodium	65	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	16
Prednisone	Prednisone	60	42
Celecoxib	Celecoxib	56	18
Ipratropium Bromide	Ipratropium Bromide	55	20
Famotidine	Famotidine	53	23
Finasteride	Finasteride	52	15
Tramadol Hcl	Tramadol Hcl	52	20
Mirtazapine	Mirtazapine	51	18
Atenolol	Atenolol	47	15
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Meloxicam	Meloxicam	46	13
Furosemide	Furosemide	43	14
Tizanidine Hcl	Tizanidine Hcl	42	21
Metformin Hcl	Metformin Hcl	41	11
Bupropion Xl	Bupropion Hcl	40	14
Glimepiride	Glimepiride	40	11
Propranolol Hcl Er	Propranolol Hcl	39	11
Metoprolol Tartrate	Metoprolol Tartrate	38	12
Triamcinolone Acetonide	Triamcinolone Acetonide	37	17
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Temazepam	Temazepam	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Ezetimibe	Ezetimibe	32	11
Torsemide	Torsemide	32	12
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Azithromycin	Azithromycin	29	22
Diazepam	Diazepam	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Nystatin	Nystatin	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Lidocaine	Lidocaine	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	18
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Valsartan	Valsartan	20	suppressed
Estradiol	Estradiol	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Indomethacin	Indomethacin	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	12
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Oxazepam	Oxazepam	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	13
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Naproxen	Naproxen	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Glipizide Er	Glipizide	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error